GlassScriptPhysician profile
Susie Chung
NPI 1760417471
$16,938.49
in general payments reported to CMS, 2019-2025
29 companies · $1,038 in 2025
The $1,038 reported for 2025 was more than what 79% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,359 · 2020: $464 · 2021: $1,904 · 2022: $2,190 · 2023: $3,509 · 2024: $3,474 · 2025: $1,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,493 · Consulting Fee: $410 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,492.53 |
| Consulting Fee | $410.00 |
| Education | $118.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $3,150.00 | 2019 | |
| Glaxosmithkline, LLC. | $1,839.05 | 2020-2025 | Benlysta, Jesduvroq |
| Bayer Healthcare Pharmaceuticals INC. | $1,686.65 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,430.86 | 2021-2025 | Lokelma, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $842.07 | 2022-2025 | Jardiance |
| Vifor Pharma, INC. | $792.13 | 2019-2024 | Veltassa, Korsuva |
| Horizon Therapeutics Plc | $788.74 | 2019-2023 | Krystexxa |
| Travere Therapeutics, INC. | $781.90 | 2023-2024 | |
| Amgen INC. | $776.42 | 2022-2025 | Tavneos, Krystexxa |
| Otsuka America Pharmaceutical, INC. | $701.42 | 2019-2025 | Jynarque |
| Calliditas Therapeutics US INC. | $559.64 | 2023-2025 | Tarpeyo |
| Mallinckrodt Hospital Products INC. | $432.15 | 2020-2024 | Acthar |
| Aurinia Pharma U.S., INC. | $402.07 | 2023-2024 | Lupkynis |
| Ardelyx, INC. | $374.86 | 2023-2025 | Ibsrela, Xphozah 30 Mg |
| Mallinckrodt Enterprises LLC | $350.31 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opko Pharmaceuticals, LLC | $321.25 | 2019-2025 | Rayaldee |
| Ani Pharmaceuticals, INC. | $299.37 | 2023 | Purified Cortrophin Gel |
| Akebia Therapeutics INC | $273.71 | 2019-2024 | Vafseo |
| Fresenius USA Marketing, INC. | $235.20 | 2019-2023 | Velphoro |
| Exact Sciences Corporation | $164.15 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $143.87 | 2021 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Intuitive Surgical, INC. | $123.45 | 2024 | |
| Novo Nordisk INC | $111.32 | 2021 | |
| Novartis Pharmaceuticals Corporation | $91.60 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $87.61 | 2019-2025 | Gardasil 9, Capvaxive |
| Pfizer INC. | $24.35 | 2023 | |
| Renalytix Ai, INC. | $16.32 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Daiichi Sankyo INC. | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susie Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.